Wealth management banker research reveals that biotech equities

Wealth management banker research reveals that biotech equities may see renewed momentum after FDA expedited approvals announced last week. Institutional buying in small-cap biopharma is at a three-month peak. Submitting this form below will send a message to your email with a link to change your password. Northwest Bank, a full-service financial institution offering a complete line of business and personal banking solutions, announced today the... As per current market sentiment, wealth management banker portfolios are increasing allocations to energy stocks, anticipating crude oil stabilizing near $78/barrel. Short-term equity volatility remains low, with VIX holding near 14, signaling investor confidence ahead of the Fed’s September policy decision.